Medpace Holdings Inc
investor.medpace.comMedpace Holdings Inc (NASDAQ: MEDP) is a contract research organization (CRO) that provides clinical development services to biopharmaceutical, biotechnology, and medical device companies. The company generates revenue by conducting outsourced clinical trials and related drug development services on a fee-for-service basis under contracts with pharmaceutical and biotech sponsors. Medpace is listed on the Nasdaq Global Select Market and filed its 10-K for fiscal year ended December 31, 2025 on February 10, 2026. The filing confirms Medpace operates as a well-known seasoned issuer, indicating a material public market capitalization as of June 30, 2025.
Products & Services
Clinical development and contract research services for pharmaceutical, biotechnology, and medical device companies, including clinical trial management and related regulatory support services.
Revenue Model
Fee-for-service contracts with biopharmaceutical, biotechnology, and medical device sponsors for outsourced clinical trial management and drug development services.
Customers & Markets
Biopharmaceutical, biotechnology, and medical device companies requiring outsourced clinical development services.
Loading...
